baber/WOPTO huggingface dataset:
Patent NZ-233001-A (NZ)
Title: Flanged food container deep drawn from thermoplastics-aluminum laminate
Inventor: EIJI TAMURA
IPC: B32B7/027
Filed: 1990-03-20
Abstract: A food packaging container (10) having a flanged container body (11,12) of a laminate sheet (1) which comprises a layer of aluminum foil (2) and at least one thermoplastic resin layer (3) joined to one surface of the foil layer (2). The container body is prepared by deep-drawing the laminate sheet (1) with the resin layer (3) inside. The aluminum foil is 40 - 200  mu m in thickness, 9.0 - 25.0 kgf/mm<2> in tensile strength, 2.5 - 9.5 kgf/mm<2> in proof stress, 10 to 40% in elongation and up to 7% in earing. The resin layer comprises a thermoplastic resin 100 - 500  mu m in thickness, 0.92 - 1.08 in the ratio of modulus of elasticity in tension in the machine direction (MD) to that in the transverse direction (TD), 0.60 - 1.40 in the MD/TD ratio of elongation and 0.40 - 1.60 in the MD/TD ratio of breaking strength.
Patent NZ-238488-A (NZ)
Title: Production of chlorine dioxide by reducing chlorate ions with methanol in aqueous sulphuric acid under reduced pressure
Inventor: FREDETTE MAURICE C J
IPC: C01B11/02
Filed: 1991-06-11
Abstract: ClO2 is produced efficiently by the redn. of NaClO3 in an aq. medium. The reaction is carried out at the b.pt. under reduced pressure. Pref. HClO3 and HCl react with consumption of Cl- and formation of HClO, which is reduced to Cl- by MeOH. If HClO is produced more quickly than it is consumed, it reacts with HCl to form Cl2. This hampers prodn. of ClO2 and also contaminates the prod.. Lower acidity with higher ClO3- concn. controls the rate of HClO formation. The concn. of acid (H2SO4) is below 7 N (above 5 N) and that of ClO3- is 2-6 (2.5-4) M. Partic. concns. used are mutually dependent. NaHSO4.Na2SO4 is obtd. as a by-prod.. MeOH consumption is approx. 0.2 (0.13-0.16) tons per ton of ClO2 produced; the latter is admixed with steam. The efficiency of ClO2 prodn. is at least 90% (exceeds 95%).
Patent NZ-239988-A (NZ)
Title: Recombinant expression of heteromeric receptors, their expression, transformed cell compositions and kits
Inventor: HUSE WILLIAM D
IPC: C07K19/00
Filed: 1991-09-27
Abstract: A composition of matter comprising a plurality of procaryotic cells containing diverse combinations of first and second DNA sequences encoding first and second polypeptides which form a heteromeric receptor exhibiting binding activity toward a preselected molecule, said heteromeric receptors being expressed on the surface of filamentous bacteriophage.
Patent NZ-240463-A (NZ)
Title: Cyclic imino derivatives, especially pyrrolidine derivatives, and pharmaceutical compositions
Inventor: HIMMELSBACH FRANK
IPC: C07D207/08
Filed: 1991-11-04
Abstract: The invention relates to cyclic imino derivatives of the general formula  B - X - A - Y - E            (I> in which A, B, E, X and Y are as defined in Claim 1, their geometrical isomers and their addition salts, in particular their physiologically tolerable addition salts with inorganic or organic acids or bases which, inter alia, have useful pharmacological properties, preferably aggregation-inhibiting effects, a process for their preparation and drugs containing these compounds.
Patent NZ-246603-A (NZ)
Title: Carbamate derivatives and fungicidal compositions thereof
Inventor: MUELLER BERND
IPC: C07C233/18
Filed: 1993-01-18
Abstract: Carbamates of the formula I wherein B is a saturated or unsaturated heterocyclic group, and the other substituents are defined in the specification, and having crop protection properties.
Patent NZ-256148-A (NZ)
Title: Packaged consumer milk: defined fat content by mixing different milk fractions
Inventor: AXELSSON KARL-GUNNAR
IPC: A23C9/15
Filed: 1993-09-16
Abstract: Consumer milk with a defined fat content packed in packages is produced by mixing two fractions consistng of milk products with different fat content. One of the fractions has a fat content below the required fat content of the consumer milk to be produced, while the other has a fat content above the required fat content of the consumer milk. The mixing of the two fractions takes place immediately prior to, or during, the filling of the consumer milk in packages.
Patent NZ-272984-A (NZ)
Title: Flush valve operated cistern, interlock mechanism comprising a latch connected with a refill actuator and having two floats
Inventor: WRIGHT SONNY RENE
IPC: E03D1/00
Filed: 1995-09-11
Abstract: An interlock mechanism (41-47) for a cistern or flush tank (1) having an underwater flush valve (3) is disclosed. The interlock mechanism is linked with the float arm (57) of an inlet valve (50). The interlock mechanism latches the float arm in its raised position in the event of a leaky flush valve (3). Thus although a single cistern volume is lost, there is no further loss. The next time a flush actuator (10) is operated the interlock mechanism in unlatched allowing the cistern to re-fill. The rising water re-sets the interlock latch mechanism.
Patent NZ-278205-A (NZ)
Title: Bottle carrier; top-gripping type in which the top of the bottle is retained between the top and bottom walls of the carrier
Inventor: BAKX MARTINUS
IPC: B65D71/46
Filed: 1994-12-14
Abstract: A top gripping carrier (11) packaging necked articles such as bottles (B) comprises top (18, 28), side (20, 26) and bottom (22, 24) walls, neck receiving apertures (38) and article retaining means (60) disposed intermediate the bottom and top wall adapted to retain the top of the associated article (B) within the carrier obscured from view from above and from the sides of the carton.
Patent NZ-294553-A (NZ)
Title: Extracts obtained from centrifuging an aqueous homogenate of whole shark cartilage; production and use
Inventor: DUPONT ERIC
IPC: A61K33/30
Filed: 1995-10-30
Abstract: The present invention relates to cartilage extracts and to a method of producing the same. Shark cartilage extracts having anti-angiogenic, direct anti-tumor proliferating, anti-inflammatory and anti-collagenolytic activities have been obtained by an improved process. The process comprises the steps of obtaining a homogenate of cartilage in an aqueous solution, this homogenate being centrifuged and further fractionated to obtain a total extract having molecules of a molecular weight comprised between 0 to 500 KDa. The composition of the liquid extract has then been investigated by different ways. Further fractionation of this extract led to the preliminary characterization of some of its active components. Due to the multiplicity of biological activities of the total liquid extract, it can be used for treating numerous diseases or conditions such as those having components selected from the group consisting of tumor proliferation, angiogenesis, inflammation and collagenolysis. This extract has no offensive effect on normal body functions. Therefore, this shark cartilage extract has a very promising therapeutic value. The process for the obtention of cartilage extracts is simple and efficient. The unexpectedly valuable products obtained by this process are therefore an indication of a new and non-obvious process.
Patent NZ-295657-A (NZ)
Title: Tetracyclic oxazepine and thiazepine derivatives, medicaments and intermediate compounds
Inventor: FERNANDEZ-GADEA FRANCISCO JAVI
IPC: C07D513/04
Filed: 1995-10-25
Abstract: PCT No. PCT/EP95/04197 Sec. 371 Date Apr. 25, 1997 Sec. 102(e) Date Apr. 25, 1997 PCT Filed Oct. 25, 1995 PCT Pub. No. WO96/14321 PCT Pub. Date May 17, 1996This invention concerns the compounds of formula (I), the pharmaceutically acceptable salts and stereoisomeric forms thereof, and also the N-oxide forms thereof.    <IMAGE>  (I)  wherein: R1 and R2 each independently are hydrogen; C1-6alkyl; C1-6alkylcarbonyl; trihalomethylcarbonyl; C1-6alkyl substituted with hydroxy, C1-6alkyloxy, carboxyl, C1-6alkylcarbonyloxy, C1-6alkyloxycarbonyl or aryl; or R1 and R2 taken together with the nitrogen atom to which they are attached may form a morpholinyl ring or an optionally substituted heterocycle; R3 to R10 each independently are hydrogen, halo, cyano, hydroxy, trifluoromethyl, trifluoromethoxy, carboxyl, nitro, amino, mono- or di(C1-6alkyl)amino, C1-6alkylcarbonylamino, aminosulfonyl, mono- or di(C1-6alkyl)-aminosulfonyl, C1-6alkyl, C1-6alkyloxy, C1-6alkylcarbonyl, C1-6alkyloxycarbonyl; R11 is hydrogen, C1-6alkyl, or trifluoromethyl; R12 is hydrogen, C1-6alkyl, cyano, or trifluoromethyl; n is zero to 6; and X is O, S, S(=O) or S(=O)2. The compounds of formula (I) may be used as therapeutic agents in the treatment or the prevention of CNS disorders, cardiovascular disorders or gastrointestinal disorders.
Patent NZ-326128-A (NZ)
Title: Electroluminescent filament
Inventor: FELDMAN MICHAEL C
IPC: H05B33/00
Filed: 1996-12-20
Abstract: An electrically activated light emitting cylindrical or other shaped composite filament.  A core conductor (401) is optionally surrounded by a first optional insulation layer (402) surrounded by an outer electrode (403) and an electroluminescent phosphor (404).  The entire assembly may be coated with a second insulation layer (406).  Light is produced by the phosphor when the core conductor (401) and the outer electrode (403) are connected to and energized by an appropriate electrical power supply.  The filament may be used to form various one-, two- and three-dimensional light emitting objects.
Patent NZ-332970-A (NZ)
Title: Vitreous crosslinked cereal flour based biological product, process for obtaining such products by polymerising and crosslinking cereal flour in an alkaline medium with a divalent crosslinking agent, and their use as removers
Inventor: BONHOURE JEAN-PAUL
IPC: B24C11/00
Filed: 1998-04-01
Abstract: The application relates to biological products obtained as a result of the polymerization and crosslinking in an alkaline medium of a gel, comprised of wheat or spelt wheat flour, in the presence of a dual-function crosslinking reagent. The application further relates to a process for obtaining the biological products, consisting in: (a) forming an aqueous dispersion of flour, (b) rendering this dispersion alkaline by adding an alkaline metal hydroxide, (c) performing polymerization and crosslinking in the presence of a dual-function crosslinking reagent, and (d) drying the resultant gel to obtain a vitreous, lightly colored product with a solid substance content of between 75 % and 85 % which is then ground into hard particles of a predetermined size.
Patent NZ-334251-A (NZ)
Title: 1,3-diheterocyclic metalloprotease inhibitors
Inventor: PIKUL STANISLAW
IPC: C07D279/06
Filed: 1997-08-22
Abstract: The compounds of formula (I) are useful as inhibitors of metalloproteases.  They may be used in the treatment of diseases, disorders and conditions characterized by metalloprotease activity, for example arthritis, cancer and ocular disorders.  In formula (I):  R1 is H;  R2 is hydrogen, alkyl, or acyl;  A is COR3 or S02R4; where R3 is alkoxy, aryloxy, heteroaryloxy, alkyl, aryl, heteroaryl, heteroalkyl, amino, alkylamino, dialkylamino, arylamino and alkylarylamino; and R4 is independently alkyl, heteroalkyl, aryl, or heteroaryl, substituted or unsubstituted;  X is O, S, SO, SO2, or NR5, wherein R5 is chosen from hydrogen, alkyl, heteroalkyl, heteroaryl, aryl, S02R6, COR7, CSR8, PO(R9)2, or may optionally form a ring with Y or W; R6 is independently alkyl, aryl, heteroaryl, heteroalkyl, amino, alkylamino, dialkylamino, arylamino, diarylamino and alkylarylamino; R7 is independently hydrogen, alkoxy, aryloxy, heteroaryloxy, alkyl, aryl, heteroaryl, heteroalkyl, amino, alkylamino, dialkylamino, arylamino and alkylarylamino; R8 is independently alkyl, aryl, heteroaryl, heteroalkyl, amino, alkylamino, dialkylamino, arylamino, diarylamino or alkylarylamino; and R9 is independently alkyl, aryl, heteroaryl or heteroalkyl;  W is independently one or more of hydrogen or lower alkyl, or a heterocycle, or is an alkylene, arylene or heteroarylene bridge between two adjacent or nonadjacent carbons (thus forming a fused ring);  Y is independently one or more of hydrogen, hydroxy, SR10, SOR4, SO2R4, alkoxy or amino, wherein amino is of formula NR11R12, where R11 and R12 are independently chosen from hydrogen, alkyl, heteroalkyl, heteroaryl, aryl, SO2R6, COR7, CSR8, PO(R9)2; and R10 is independently hydrogen, alkyl, aryl or heteroaryl;  Z is nil, a spiro moiety or an oxo group substituted on the heterocyclic ring; and  n is 1-4.
Patent NZ-334288-A (NZ)
Title: Genetically modified organisms using quiescent cells (G0) for nuclear transfer from donor embryo to recipient cell (cloning)
Inventor: CAMPBELL KEITH HENRY STOCKMAN
IPC: A61K35/54
Filed: 1999-02-19
Abstract: A method of reconstituting an animal embryo involving transferring the nucleus from a quiescent donor cell into a suitable recipient cell. The donor cell is quiescent, in that it is caused to exit from the growth and division cycle at G1 and to arrest in the G0 state. Nuclear transfer may take place by cell fusion. The reconstituted embryo may then give rise to one or more animals.
Patent NZ-336857-A (NZ)
Title: Manufacturing terminal block by moulding plastic around terminals formed from flat strip
Inventor: REIMOLD GUNTHER
IPC: H01H61/02
Filed: 1999-07-21
Abstract: A terminal block 41 for an electrical switching device is formed by forming a terminal section from a sheet metal blank.  The formed terminal section is then placed in a mould, where the terminal block is embedded into a plastic material to from the completed terminal block.  Terminals 12, 45, 19 protrude from the terminal block so that electrical conductors can be connected to them.  The connections between the terminals in the block are completely covered by the plastic material.  The terminal block may be used to make a time switch.
Patent NZ-337054-A (NZ)
Title: Microparticles PLA and PLG with adsorbed viral antigen to stimulate immune responses particularly for intracellular viruses such as HSV-1 or HSV-2, varicella zoster virus. epstein-barr virus or cytomegalovirus (CMV)
Inventor: O'HAGAN DEREK
IPC: A61K39/245
Filed: 1998-01-29
Abstract: A composition comprising (i) a selected vial antigen absorbed to a poly(-a-hydroxy acid) microparticle and (ii) a pharmaceutically acceptable excipients, with the provisos that (a) the composition does not comprise an antibody specific for the viral antigen and (b) the microparticles are not lamellar particles which are at least in part crystalline. The microparticle is formed from a poly(a-hydroxy acid) selected from the group consisting of poly(L-lactide), poly(D,L-lactide) and poly(D,L-lactide-co-glycolide). The viral antigen is gp120, p24gag, influenza A haemagglutinin, or herpes simplex virus gD2.
Patent NZ-512905-A (NZ)
Title: Automated price improvement protocol processor
Inventor: LUTNICK HOWARD
IPC: G06Q30/08
Filed: 1999-11-05
Abstract: A data processing system for implementing transaction management of auction-based trading for specialised items such as fixed income instruments. The data processing system provides a highly structured trading protocol implemented through a sequence of trading paradigms. User workstations (10) are linked to a central server (20), which includes controlling software. Access to trading activity is accomplished at communication server (30) and remote server (40). In accordance with the protocol, bids and offers may be entered into the system, or cleared, or participants given the opportunity to revise their bids and offers, depending on the trading state of the system. The protocol enhances trading efficiency, rewards market makers, and fairly distributes market opportunity to system users.
Patent NZ-513357-A (NZ)
Title: Inhalation device with powder dislodging member for accumulated powder on surfaces of flow path, with cap covering mouthpiece
Inventor: STRID HANS
IPC: A61M15/00
Filed: 1998-03-13
Abstract: Mouthpiece 2 is rotatable relative to housing  6.  Cap 169  ocvers mouthpiece 2 and engages threadably with housing 6.  The  cap  and  mouthpiece are configured  such  that  as mouthpiece 2 is rotated relative to the housing  in  one  of screwing or unscrewing of cap 169, and is fixed relative  to housing  6  in  the other of screwing or unscrewing  of  the cap.
Patent NZ-513399-A (NZ)
Title: Gate with rotation of post to raise and rotate barrier
Inventor: STUBBE BERNHARD
IPC: E05F13/04
Filed: 2001-08-08
Abstract: Rotation of post section 4 causes barrier mounting 6 to be raised (so that latch 17 is released) and then rotated as shown.
Patent NZ-514432-A (NZ)
Title: Nasal support device for domestic mammals and method
Inventor: BLACH EDWARD L
IPC: A61F5/08
Filed: 2000-03-07
Abstract: A  device and method for facilitating air flow in  the nasal  passage  of  a  domestic animal.  The  nasal  support devices  (NSD)  are useful for facilitating  airflow  during rest,   physical   exertion,   respiratory   ailment,   etc. Components  and  methods to facilitate  application  of  the support device to the nose of an animal are also disclosed.
Patent NZ-517498-A (NZ)
Title: Improvements relating to activity surfaces
Inventor: EVERETT ROBERT
IPC: E01C13/00
Filed: 2000-09-29
Abstract: A portion of an activity surface provided on a movable tray for use in a region of the activity surface that is prone in use to a high level of wear, the portion comprising a first and a second equivalent sections compatible and reversibly co-operable in a similar manner with another region of the activity surface, wherein the tray is arranged to be moved between a first activity surface co-operating position where the first section co-operates with and provides the high wear region of the activity surface, and a second activity surface co-operating position where the second section replaces the first section and co-operates with and provides the high wear region of the activity surface.
Patent NZ-517789-A (NZ)
Title: Low cost long distance RFID reading
Inventor: MONICO DOMINICK L
IPC: H01Q9/28
Filed: 2000-09-28
Abstract: In the production radio frequency (RF) sensable objects, it is possible to produce a package, envelope (10), or like container which has enhanced read distance, producable by a simple method. Large areas are printed on the envelope or package in conductive ink (12, 14) which are separated by a non-conductive portion (15) of the package or envelope and function as an RF antenna. Then by placing an otherwise conventional label (17) with an RFID chip (19) associated with it so that it bridges the conductive ink portions of the RF antenna, a much easier to sense or read product is produced. The conductive ink can be applied in a pattern, logo, and letters or character indicia. The label may have conductive pressure sensitive adhesive on one face, which actually connects the antenna sections to the RFID chip to form the operable structure that can be sensed by an RF receiver at a distance of three meters or more.
Patent NZ-519750-A (NZ)
Title: Self-discharging freight container for bulk solids
Inventor: HANNA JOHN WILLIAM
IPC: B65D88/56
Filed: 2000-12-18
Abstract: A self-discharging freight container (14) for bulk solids of the type which discharge by tilting so that a hinged wall (60) and a floor (32) become coplanar, as a container (14) braced by a pair of triangulating braces (22) adjacent the hinge (8). Rams (42) extending from the static frame (2) push against the braces (22) and rotate the container (14) by 40 DEG . Side-by-side and end-to-end versions tip to the left and right. A crane lifted version (not shown) is included.
Patent NZ-524765-A (NZ)
Title: Non-invasive measurement of suprasystolic signals
Inventor: SHARROCK NIGEL E
IPC: A61B5/022
Filed: 2001-07-19
Abstract: An apparatus for assessing cardiovascular status of a mammal comprises a system for locally applying a pressure to an artery capable of restricting blood flow through said artery, a wideband external pulse transducer having an output and situated to measure suprasystolic signals proximate to said artery, and a computing device receiving said output for calculating vascular compliance values. The method described is particularly useful for determining cardiac output, assessing whether a pregnant female has preeclampsia or a patient has cardiac insufficiency, or assessing cardiac arrhythmias.
Patent NZ-525881-A (NZ)
Title: Switch unit
Inventor: PARK HYUNG SIK
IPC: H01H9/16
Filed: 2001-11-21
Abstract: A switch unit allows a user to perform an on-and-off switching control of a load which is installed in a certain place without having the user move to the load position and confirm the control status of the load. The switch unit includes a local switching unit having a plurality of buttons each corresponding to each load which is installed in a current place, for directly selecting a load to be switching-controlled, an overall switching unit fabricated in the form of a dial, for selecting a load to be switching-controlled, an overall display unit having a number of LEDs, for displaying the switching control state of each load, an all-off switch which is slightly sunk from the surface of the switch unit, for switching all the loads entirely, and a remote controller signal receiver for receiving a remote controller signal. The switch unit further includes a FND display unit for displaying a load corresponding to the current dial position in the overall switching unit with a numerical symbol. Thus, a power source can be easily, conveniently and efficiently used and managed, to thereby provide users with a considerable power saving effect and conveniences.
Patent NZ-526237-A (NZ)
Title: Neovascularisation prevention barrier
Inventor: HOLLINGSWORTH SIMON JOHN
IPC: A61F2/06
Filed: 2001-11-28
Abstract: A neovascularisation prevention barrier comprises first and second lamellar portions joined by a connecting bridge. The barrier is implanted during primary varicose vein surgery such that the first and second portions are on opposite sides of the cribriform fascia, and acts as a barrier to neo-vascularisation to avoid recurrent varicose veins.
Patent NZ-531588-A (NZ)
Title: A beam and a method of forming same
Inventor: CHARLWOOD MATTHEW
IPC: E04C3/07
Filed: 2004-03-05
Abstract: A beam that has a metal outer skin which is roll formed into a closed shape and an interior core formed from an expanded foam material. The outer surfaces of the inner core are bonded to the inner surfaces of the outer skin.
Patent NZ-536559-A (NZ)
Title: Use of a metabotropic glutamate receptor 5 antagonist for the treatment of gastro-esphageal reflux disease
Inventor: LEHMANN ANDERS
IPC: A61P1/04
Filed: 2003-06-19
Abstract: The disclosure relates to the use of metabotropic glutamate receptor 5 (mGluR5) antagonists for the inhibition of transient lower esophageal sphincter relaxations (TLESRs). These metabotropic glutamate receptor 5 antagonists are also suitable for the treatment of gastro-esophageal reflux disease (GERD), as well as for the treatment of regurgitation and asthma.
Patent NZ-536880-A (NZ)
Title: Aqueous solution of non-colloidal silicic acid and boric acid
Inventor: KROS WILLEM ADRIANUS
IPC: C05G3/00
Filed: 2003-05-28
Abstract: Disclosed herein is an aqueous solution, comprising boric acid, non-colloidal silicic acid and a water absorbing additive, wherein silicon as silicic acid is present between 0.01 and 2 wt. % and boron as boric acid is present between 0.0001 and 4 wt. %, wherein the solution has a pH-value below 2. This solution contains bioavailable silicon (in the form of non-colloidal silicic acid and boron (in the form of boric acid) that can be used to strengthen plants or trees, or as food or feed additives to humans and animals, and the solution is stable for more than a year. A method for the preparation of a solution in which one or more silicon and boron compounds are hydrolysed in an acidic solution containing one or more solved water absorbing additives is also disclosed.